- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Merck, Pfizer and AZ Best at Digital Engagement with Physicians, Says Report
January 25, 2016.
Merck, Pfizer and AstraZeneca are seen as "ahead of the curve in digital engagement with doctors worldwide", according to a worldwide study on doctors and their digital habits conducted by Indegene (Iselin, NJ).
GSK, Abbott, Novartis and Sanofi were also mentioned for their "notable performance on the digital scale."
The study surveyed over 1600 doctors and revealed that, across markets, HCPs predominately preferred face-to-face interactions, online-detailing, and email. The US and Japan, were found to be significantly "ahead of the curve" with regard to using digital to engage their patients. Doctors in China and India seemed comfortable with more than 2-3 text messages and 4 emails in a month, whereas in the US, doctors want face to face, online, app, text and websites detailing once a month.
A copy of the report can be requested here
